Susquehanna International Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4M Buy
464,569
+445,884
+2,386% +$20.8M ﹤0.01% 2083
2025
Q4
$905K Sell
18,685
-1,893
-9% -$93.8K ﹤0.01% 7406
2025
Q3
$971K Sell
20,578
-50,626
-71% -$2.44M ﹤0.01% 7434
2025
Q2
$3.44M Buy
71,204
+64,378
+943% +$3.29M ﹤0.01% 4697
2025
Q1
$379K Buy
6,826
+1,495
+28% +$80.9K ﹤0.01% 9535
2024
Q4
$257K Sell
5,331
-122,876
-96% -$6.25M ﹤0.01% 10157
2024
Q3
$7.39M Sell
128,207
-17,160
-12% -$926K ﹤0.01% 3018
2024
Q2
$7.05M Sell
145,367
-62,783
-30% -$3.03M ﹤0.01% 2922
2024
Q1
$10.1M Buy
208,150
+110,421
+113% +$5.39M ﹤0.01% 2590
2023
Q4
$4.86M Buy
97,729
+7,065
+8% +$345K ﹤0.01% 3746
2023
Q3
$4.86M Buy
+90,664
New +$4.83M ﹤0.01% 3577
2023
Q2
Sell
-59,722
Closed -$3.21M 13060
2023
Q1
$3.25M Sell
59,722
-121,633
-67% -$5.92M ﹤0.01% 4166
2022
Q4
$8.78M Sell
181,355
-198,858
-52% -$8.73M ﹤0.01% 2449
2022
Q3
$14.5M Buy
380,213
+327,880
+627% +$14.6M ﹤0.01% 1741
2022
Q2
$2.62M Buy
52,333
+17,995
+52% +$955K ﹤0.01% 4336
2022
Q1
$1.76M Sell
34,338
-18,371
-35% -$949K ﹤0.01% 5764
2021
Q4
$2.64M Sell
52,709
-113,945
-68% -$5.64M ﹤0.01% 4878
2021
Q3
$8.03M Buy
166,654
+160,149
+2,462% +$8.14M ﹤0.01% 3195
2021
Q2
$343K Sell
6,505
-130,194
-95% -$6.79M ﹤0.01% 10484
2021
Q1
$6.76M Sell
136,699
-18,528
-12% -$890K ﹤0.01% 3389
2020
Q4
$7.54M Buy
155,227
+116,038
+296% +$5.72M ﹤0.01% 2847
2020
Q3
$1.97M Sell
39,189
-76,404
-66% -$3.93M ﹤0.01% 4655
2020
Q2
$5.9M Buy
115,593
+58,169
+101% +$2.83M ﹤0.01% 2778
2020
Q1
$2.51M Buy
+57,424
New +$2.75M ﹤0.01% 3574
2019
Q3
Sell
-11,084
Closed -$478K 10798
2019
Q2
$480K Buy
+11,084
New +$471K ﹤0.01% 7355
2019
Q1
Sell
-11,652
Closed -$499K 9773
2018
Q4
$506K Buy
+11,652
New +$514K ﹤0.01% 6011
2018
Q1
Sell
-65,094
Closed -$2.71M 10119
2017
Q4
$2.8M Buy
65,094
+50,722
+353% +$2.34M ﹤0.01% 3349
2017
Q3
$716K Sell
14,372
-30,763
-68% -$1.49M ﹤0.01% 5888
2017
Q2
$2.16M Buy
45,135
+25,954
+135% +$1.24M ﹤0.01% 3779
2017
Q1
$868K Sell
19,181
-50,305
-72% -$2.13M ﹤0.01% 5430
2016
Q4
$2.81M Buy
69,486
+54,886
+376% +$2.16M ﹤0.01% 3381
2016
Q3
$558K Sell
14,600
-56,200
-79% -$2.26M ﹤0.01% 5871
2016
Q2
$2.96M Buy
70,800
+57,164
+419% +$2.34M ﹤0.01% 2952
2016
Q1
$548K Buy
13,636
+2,738
+25% +$110K ﹤0.01% 6234
2015
Q4
$465K Buy
+10,898
New +$501K ﹤0.01% 6900
2015
Q1
Sell
-59,392
Closed -$2.84M 9901
2014
Q4
$2.71M Buy
+59,392
New +$2.88M ﹤0.01% 3909
2014
Q2
Sell
-5,013
Closed -$266K 10078
2014
Q1
$262K Sell
5,013
-16,462
-77% -$833K ﹤0.01% 7803
2013
Q4
$1.15M Sell
21,475
-35,902
-63% -$1.85M ﹤0.01% 5255
2013
Q3
$2.9M Buy
+57,377
New +$2.92M ﹤0.01% 3534

Other funds holding SNY

Susquehanna International Group's SNY Position: Q1 2026 in Review

Susquehanna International Group increased its Sanofi (SNY) stake by 2,386% in Q1 2026, buying an estimated $20.8M and bringing the position to 464,569 shares worth $22.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Susquehanna International Group first reported a position in SNY in Q3 2013 and has held it in 39 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Susquehanna International Group held 464,569 shares of Sanofi worth $22.4M as of Q1 2026.
  • Susquehanna International Group bought 445,884 Sanofi shares in Q1 2026, an estimated $20.8M.
  • Sanofi made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2083 holding.
  • Susquehanna International Group first reported a position in Sanofi in Q3 2013 and has held it in 39 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.